11 December 2018 | NewsVaccine safety in Australia AusVaxSafety summary report 2016-17Read the full article
The PHN Immunisation Support Program is a service funded by the Commonwealth Government, targeting staff working at Primary Health Networks (PHNs), state and territory health departments, public health units and other key stakeholder organisations.
NCIRS and NPS MedicineWise are partners leading the development and implementation of this program. NCIRS is the content lead for this important initiative.
The program focuses on building a community of practice by:
creating an environment that facilitates collaboration and networking
providing a hub for accessing resources and expertise
enabling the sharing of skills and knowledge between experienced and less experienced staff.
Specifically, the program provides:
access to an online platform that provides high-quality resources, education, news and updates, network directories. This platform enables PHNs to connect and share ideas
development of resources and education where significant gaps are identified
networking opportunities, such as teleconferences and face-to-face events
central coordination of all program activities.
Visit www.phnimmunise.org.au for more information.
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.